Newsletter | November 26, 2024

11.26.24 -- Sourcing Plasmid DNA From CDMOs Just Got More Challenging

SPONSOR

Webinar: What’s Wrong with My Trial? Uncovering the Root Cause of Clinical Trial Troubles

Clinical trials often face unforeseen challenges that can derail progress and necessitate costly corrective efforts. However, many of these challenges can be avoided with proactive planning and early intervention. Explore the most critical steps companies can take to prevent trials from reaching a point of crisis and the importance of addressing systemic issues before they escalate. Click here to learn more.

FEATURED EDITORIAL

Sourcing Plasmid DNA From CDMOs Got More Challenging — Here's Why

The demand for plasmid DNA products is intrinsically linked to unique market conditions and funding environments. Here's what's driving them.

INDUSTRY INSIGHTS

The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems

This article examines two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.

Impact Of Supplier Choice On APAC Clinical Trial Execution

Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.

SOLUTIONS

Complex Randomization Delivered Successfully

Early Drug Development Made Easy With Small Quantities